Protara Therapeutics, Inc. (TARA)

Protara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	49.66	162.8	39.59	24.13	35.72
Short-Term Investments	105.9	7.49	25.99	60.24	55.51
Cash & Short-Term Investments	155.55	170.29	65.58	84.37	91.23
Cash Growth	-8.65%	159.67%	-22.27%	-7.52%	-45.89%
Other Current Assets	3.95	1.86	3.13	1.78	1.88
Total Current Assets	159.5	172.16	68.71	86.15	93.11
Net Property, Plant & Equipment	3.93	5.28	6.56	7.87	8.89
Goodwill	-	-	-	-	29.52
Long-Term Investments	42.34	-	-	17.89	39.47
Other Long-Term Assets	3.7	4.02	3.69	1.39	1.61
Total Assets	209.47	181.45	78.95	113.29	172.6
Accounts Payable	3.47	4.43	2.43	1.59	0.95
Accrued Expenses	6.23	5.41	2.73	3.24	2.49
Current Portion of Leases	1.24	1.12	0.98	0.92	0.86
Total Current Liabilities	10.94	10.96	6.15	5.74	4.3
Long-Term Leases	2.12	3.36	4.48	5.47	6.38
Total Long-Term Liabilities	2.12	3.36	4.48	5.47	6.38
Total Liabilities	13.06	14.32	10.63	11.21	10.68
Shareholders' Equity	196.41	167.13	68.32	102.08	161.91
Total Liabilities & Equity	209.47	181.45	78.95	113.29	172.6
Total Debt	3.36	4.48	5.47	6.38	7.24
Net Cash (Debt)	152.2	165.81	60.11	77.99	83.99
Net Cash Growth	-8.21%	175.83%	-22.92%	-7.15%	-49.86%
Net Cash Per Share	3.55	8.05	5.30	6.93	7.48
Book Value	196.41	167.13	68.32	102.08	161.91
Book Value Per Share	4.59	8.12	6.03	9.07	14.41
Tangible Book Value	196.41	167.13	68.32	102.08	132.4
Tangible Book Value Per Share	4.59	8.12	6.03	9.07	11.79

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q